Search results for "age factors"

showing 10 items of 1176 documents

Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65: a retrospective study

2017

Abstract Background To analyse the clinical, epidemiological, microbiological and prognostic differences of pyogenic liver abscess (PLA) in older (≥ 65 years of age) versus younger patients (< 65 years). Methods Multicentre, retrospective cohort study in all patients with PLA admitted to two Spanish hospitals from January 2000 to January 2014. Cases were divided into two age groups (< 65 years and ≥65 years) for comparison of clinical, epidemiological and microbiological characteristics as well as treatment. Results Of 98 patients analysed, 40 patients were younger than 65, and 58 were aged 65 or older. Significant associations in the older group were found with female sex (adjusted odds ra…

AdultMalemedicine.medical_specialtyEpidemiologylcsh:GeriatricsChronic liver diseaseMicrobiologyBiliary diseaseCohort Studies03 medical and health sciencesYoung Adult0302 clinical medicineInternal medicineEpidemiologymedicineEscherichia coliHumansMortalityEscherichia coli InfectionsAgedRetrospective StudiesPyogenic liver abscessAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceAge FactorsRetrospective cohort studyOdds ratioPyogenicMiddle Agedmedicine.diseasePrognosisSurgeryLiver abscesslcsh:RC952-954.6Liver Abscess Pyogenic030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleGeriatrics and GerontologybusinessLiver abscessResearch ArticleBMC Geriatrics
researchProduct

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.

2011

Aims: We assessed whether a cardiovascular risk model based on classic risk factors (e.g. cholesterol, blood pressure) could refine disease prediction if it included novel biomarkers (C-reactive protein, N-terminal pro-B-type natriuretic peptide, troponin I) using a decision curve approach which can incorporate clinical consequences. Methods and results: We evaluated whether a model including biomarkers and classic risk factors could improve prediction of 10 year risk of cardiovascular disease (CVD; chronic heart disease and ischaemic stroke) against a classic risk factor model using a decision curve approach in two prospective MORGAM cohorts. This included 7739 men and women with 457 CVD …

AdultMalemedicine.medical_specialtyEpidemiologymedicine.drug_classBlood PressureDiseaseRisk AssessmentDecision Support TechniquesSex FactorsPredictive Value of TestsRisk FactorsInternal medicineTroponin INatriuretic Peptide BrainmedicineNatriuretic peptideHumansRisk thresholdProspective StudiesFramingham Risk Scorebusiness.industryTroponin IAge FactorsMiddle AgedPrognosisPeptide FragmentsSurgeryEuropeBlood pressureC-Reactive ProteinCholesterolCardiovascular DiseasesCohortBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean journal of preventive cardiology
researchProduct

Chemically and electrically induced sweating and flare reaction

2004

Both thin afferent (nociceptors) and efferent (sympathetic sudomotor) nerve fibers can be activated electrically and chemically, resulting in neurogenic erythema and sweating. These reactions have been used before to assess the impairment of sympathetic and nociceptor fibers in humans. In this study, electrically induced sweating and erythema were assessed simultaneously in the foot dorsum and thigh, and were compared to chemically induced activation. Reproducible intensity-response relations (stimulation intensities 0-30 mA, 1 Hz) were obtained from 32 subjects. The steepest increase of the sweat response was induced at lower intensities as compared to that of the erythema (18.3 mA vs. 25.…

AdultMalemedicine.medical_specialtyErythemaEfferentSweatingStimulationFunctional LateralityCellular and Molecular NeuroscienceSex FactorsInternal medicineReflexLaser-Doppler FlowmetrymedicineHumansAgedSkinAnalysis of VarianceNeurogenic inflammationintegumentary systemFootEndocrine and Autonomic SystemsChemistryAge FactorsReproducibility of ResultsDose-Response Relationship RadiationMiddle AgedAcetylcholineElectric StimulationStimulation ChemicalSudomotorAutonomic nervous systemEndocrinologyThighErythemaAnesthesiaNociceptorFemaleNeurology (clinical)medicine.symptomAcetylcholinemedicine.drugAutonomic Neuroscience
researchProduct

Hematinic de?ciencies in patients with recurrent aphthous stomatitis : variations by gender and age

2017

Background The aim of this study was to evaluate the association between hematinic deficiencies and recurrent aphthous stomatitis (RAS). Material and Methods 517 RAS patients and 187 healthy controls were enrolled in the present study. Hematinic deficiencies, including serum ferritin, folic acid, and vitamin B12 deficiencies were assessed for each participant. Gender and age were taken into account and the collected data were statistically analysed. Results Compared with the healthy controls, a significantly higher overall frequency of hematinic deficiencies was found in RAS patients (p<0.001). When gender and age were taken into account, significant differences in hematinic deficiencies we…

AdultMalemedicine.medical_specialtyFolic Acid DeficiencyRecurrent aphthous stomatitisLogistic regressionAge and gender03 medical and health sciencesYoung Adult0302 clinical medicineSex FactorsRecurrenceInternal medicinepolycyclic compoundsMedicineHumansIn patientHematinicVitamin B12Young adultGeneral DentistryStomatitisOral Medicine and Pathologybusiness.industryResearchAge FactorsVitamin B 12 Deficiency030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Otorhinolaryngology030220 oncology & carcinogenesisFerritinsUNESCO::CIENCIAS MÉDICASSurgeryFemaleStomatitis Aphthousbusiness
researchProduct

Kinematic analysis of motor strategies in frail aged adults during the Timed Up and Go: how to spot the motor frailty?

2015

Asma Hassani,1 Alexandre Kubicki,2,3 Vincent Brost,1 France Mourey,2,4 Fan Yang1 1Laboratoire LE2I CNRS 6306, Universit&amp;eacute; de Bourgogne, Dijon, France; 2Institut National de la Sant&amp;eacute; et de la Recherche M&amp;eacute;dicale (INSERM), Cognition Action et Plasticit&amp;eacute; Sensori-Motrice, Campus Universitaire, Universit&amp;eacute; de Bourgogne, Dijon, France; 3Centre Hospitalier Universitaire de Dijon, H&amp;ocirc;pital de Champmaillot, Dijon, France; 4Facult&amp;eacute; de M&amp;eacute;decine, Universit&amp;eacute; de Bourgogne, Dijon, France Objective: The purpose of this work was to analyze and compare the movement kinematics of sit-to-stand (STS) and back-to-sit (B…

AdultMalemedicine.medical_specialtyFrail ElderlyMovementKinematicsTimed Up and Go testTimed Up and Go testsarcopeniaYoung AdultPhysical medicine and rehabilitationElderly persons[ INFO.INFO-BI ] Computer Science [cs]/Bioinformatics [q-bio.QM]fallsmedicineHumansFrail elderlyalzheimers-diseaseOriginal ResearchriskAged 80 and overfrailty effectsWork (physics)agingAge FactorsGeneral Medicinedwelling older-adultsmobilityBiomechanical Phenomenakinematicselderly personsClinical Interventions in AgingPhysical therapyFemaleGeriatrics and Gerontology[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM]Psychologyhuman activitiesTimed up and go
researchProduct

An open-safety study of dual antiviral therapy in real-world patients with chronic hepatitis C

2010

Purpose Treatment of patients with chronic hepatitis C with alpha-interferon and ribavirin usually produces adverse events within the first 3 months. We aimed to assess safety and predictors of discontinuation or dose modification of these drugs. Methods Observational study of 312 patients with predominantly genotype 1 chronic hepatitis C treated openly along 5 years in a clinical practice setting. Results Eighty-four percent of patients experienced at least one adverse event (853 events in total, 3.3 per patient on average). Incidence rate was higher during the first 90 days and decreased thereafter (<5%). Discontinuation rates at 30 and 90 days and at end of treatment were 2, 4 and 8%, re…

AdultMalemedicine.medical_specialtyGenotypeEpidemiologyadverse eventHepacivirusAntiviral AgentsSettore MED/01 - Statistica MedicaMedication Adherencechemistry.chemical_compoundChronic hepatitisInternal medicineRibavirinHumansMedicinePharmacology (medical)Dual therapyAdverse effectDose ModificationSettore MED/12 - GastroenterologiaDose-Response Relationship Drugbusiness.industryIncidenceRibavirinAge FactorsAntiviral therapyInterferon-alphainterferonpredictionHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseSurgeryDiscontinuationchemistryDrug Therapy CombinationFemalehepatitis CbusinessPharmacoepidemiology and Drug Safety
researchProduct

Association between M467T and 114 C--A variants within the SLC3A1 gene and some phenotypical traits in cystinuria patients from Spain.

2000

Cystinuria is an inherited metabolic disease characterized by an abnormal urinary excretion of cystine and dibasic amino acids. Formation of renal calculi, recurrent infections and renal failure are the main complications of this disease. The SLC3A1 gene, which codes for a dibasic amino acid transporter protein, is involved in the pathogenesis of cystinuria. We investigated the possible association between molecular variants (M467T, E483X, T216 M and 114 C--A) within the SLC3A1 gene and some phenotypical traits in a Spanish area. The study population consisted of 45 cystinuria patients, 42 cystinuria relatives and 81 healthy control subjects. Only the M467T mutation was found in chromosomes…

AdultMalemedicine.medical_specialtyGenotypeUrinary systemCystineBiologychemistry.chemical_compoundKidney CalculiSex FactorsMale Urogenital DiseasesInternal medicineGenotypeGeneticsmedicineHumansAlleleAmino AcidsChildAllele frequencyGenetics (clinical)AllelesCystinuriaMembrane GlycoproteinsPolymorphism GeneticMediterranean RegionAge FactorsCystinuriamedicine.diseaseFemale Urogenital DiseasesEndocrinologyPhenotypechemistrySpainAminoaciduriaMutationPopulation studyAmino Acid Transport Systems BasicRegression AnalysisFemaleCarrier ProteinsHuman genetics
researchProduct

Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-alph…

2003

Ageing is associated with chronic, low grade inflammatory activity leading to long term tissue damage, and systemic chronic inflammation has been found to be related to mortality risk from all causes in older persons.1 Also, the genetic constitution of the organism interacting with systemic inflammation may cause defined organ specific illnesses. Thus, age related diseases such as Alzheimer’s disease (AD), Parkinson’s disease, atherosclerosis, type 2 diabetes, sarcopenia, and osteoporosis, are initiated or worsened by systemic inflammation, suggesting the critical importance of unregulated systemic inflammation in the shortening of survival in humans.1–3 Accordingly, proinflammatory cytokin…

AdultMalemedicine.medical_specialtyGenotypemedicine.medical_treatmentDNA Mutational AnalysisLongevityInflammationSingle-nucleotide polymorphismBiologySystemic inflammationPolymorphism Single NucleotideProinflammatory cytokineGene FrequencyInternal medicineGeneticsmedicineHumansAllelePromoter Regions GeneticGenetics (clinical)AgedGeneticsAged 80 and overInflammationTumor Necrosis Factor-alphaAge FactorsDNAMiddle AgedInterleukin-10Interleukin 10CytokineEndocrinologyImmunologyFemalemedicine.symptomCentenarianLetter to JMGJournal of medical genetics
researchProduct

Current practice of chronic hepatitis B treatment in Southern Italy

2012

Abstract Background Treatment choice for chronic HBV infection is a continuously evolving issue, with a wide range of options. We aimed to evaluate the current practice of HBV therapies in the real world in Southern Italy. Methods A prospective study enrolling over a six month period (February–July 2010) all consecutive HBsAg positive subjects, never previously treated, referred to 16 liver units in two Southern Italy regions (Calabria and Sicily). Results Out of 247 subjects evaluated, 116 (46.9%) had HBV-DNA undetectable or lower than 2000 UI/ml. There were 108 (43.7%) inactive carriers, 103 (41.7%) chronic hepatitis, and 36 (14.6%) liver cirrhosis. Antiviral treatment was planned in 94 (…

AdultMalemedicine.medical_specialtyHBsAgGuanineCirrhosisOrganophosphonatesPyrimidinonesNucleosides analoguesAntiviral AgentsPolyethylene GlycolsYoung AdultHepatitis B ChronicChronic hepatitisInterferonPegylated interferonInternal medicineHBVInternal MedicinemedicineHumansHepatitis B e AntigensPractice Patterns Physicians'TenofovirProspective cohort studyAgedAged 80 and overTelbivudinebusiness.industryAdenineAge FactorsInterferon-alphaNucleosidesMiddle AgedHBV; Interferon; Nucleosides analogues; Nucleotides analoguesNucleotides analoguesmedicine.diseaseRecombinant ProteinsItalyLamivudineCurrent practiceImmunologyInterferonFemalePreviously treatedbusinessThymidinemedicine.drugEuropean Journal of Internal Medicine
researchProduct

Sociocognitive factors associated with nonadherence to medication after hospital discharge

2010

Poor adherence to prescribed medication is a well-known problem and continues to be a major challenge in all medical specialties. Unlike previous studies that have mainly focused on nonadherence behaviors in specific diseases, this study sought to examine socio-cognitive factors associated with nonadherence behavior in a sample of a general clinical population. A questionnaire investigating socio-demographic and cognitive factors and a telephone follow-up interview were administered to 84 patients recruited in a General Medicine Unit before their discharge. Half of the participants were informed about that follow-up procedure. One month after hospital discharge, 42% of uninformed patients r…

AdultMalemedicine.medical_specialtyHealth Knowledge Attitudes PracticePopulationcognitive failuresMedication AdherencePoor adherencepostdischarge patientrisk perceptionSurveys and QuestionnairesHospital dischargeHumansMedicineSurveys and QuestionnaireAge FactorRisks and benefitseducationPsychiatryApplied PsychologyAgedadherence monitoringAged 80 and overeducation.field_of_studycognitive failureSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryadherence monitoring; cognitive failures; postdischarge patients; risk perceptionAge FactorsCognitionMiddle AgedPatient DischargeRisk perceptionPsychiatry and Mental HealthAdherence monitoringFemalebusinesspostdischarge patientsHuman
researchProduct